In English | En español
Questions About Cancer? 1-800-4-CANCER

Clinical Trials Search Results

Clinical Trials Search Results

Initial search results include only NCI-sponsored clinical trials. To search all trials, click the "REFINE SEARCH" button, scroll down to the Trial ID/Sponsor section and select the "All" check box in the Sponsor of Trial section.

View Content for:
Display:
  •          
Help with display options.
Results 1-25 of 106 for your search:
Drug:  tretinoin
Find trials that include:  Any drugs shown
Trial Status:  Closed
Start Over
        Show
1.

Phase: Phase IV
Type: Treatment
Status: Completed
Age: 75 and under
Sponsor: Other
Protocol IDs: Pethema LPA-99 protocol, NCT00465933

2.

Phase: Phase III, Phase II
Type: Treatment
Status: Closed
Age: 18 to 60
Sponsor: Other
Protocol IDs: AMLSG07-04, NCT00151242

3.

Phase: Phase III
Type: Treatment
Status: Closed
Age: 15 to physiologic 59
Sponsor: Other
Protocol IDs: MRC-LEUK-AML12, EU-95001, NCT00002658

4.

Phase: Phase III
Type: Treatment
Status: Closed
Age: 16 to 74
Sponsor:
Protocol IDs: EORTC-06952, ITA-GIMEMA-AIEOP-1, NCT00002701

5.

Phase: Phase III
Type: Treatment
Status: Closed
Age: any age
Sponsor:
Protocol IDs: MRC-LEUK-ATRA, EU-95038

6.

Phase: Phase III
Type: Treatment
Status: Closed
Age: 18 and over
Sponsor: Pharmaceutical / Industry
Protocol IDs: LIGAND-L1057-77, NCI-V97-1291

7.

Phase: Phase III
Type: Treatment
Status: Completed
Age: Any age
Sponsor: NCI
Protocol IDs: NCI-2012-02811, C9710, CDR0000067126, CALGB-C9710, U10CA031946, CAN-NCIC-AL3, COG-C9710, ECOG-C9710, SWOG-C9710, CAN-NCIC-C9710, AL3, NCT00003934

8.

Phase: Phase III
Type: Treatment
Status: Closed
Age: 60 and over
Sponsor: Other
Protocol IDs: LRF-AML14, EU-20016, NCT00005823, ISRCTN62207270

9.

Phase: Phase III
Type: Treatment
Status: Closed
Age: Any age
Sponsor: Other
Protocol IDs: MRC-LEUK-AML-HR, EU-20008, NCT00005863

10.

Phase: Phase III
Type: Treatment
Status: Closed
Age: any age
Sponsor: NCI
Protocol IDs: E-2491, ALSG-91/M5, CAN-NCIC-AL2, CCG-2911, CLB-9191, POG-9220, SWOG-9129, EST-2491, INT-0129, E2491, BL10

11.

Phase: Phase III
Type: Treatment
Status: Completed
Age: 18 and over
Sponsor:
Protocol IDs: MSKCC-92017A1, NCI-V92-0096

12.

Phase: Phase III
Type: Treatment
Status: Closed
Age: under 65
Sponsor:
Protocol IDs: EORTC-06915

13.

Phase: Phase III
Type: Treatment
Status: Closed
Age: 18 to 70
Sponsor: Other
Protocol IDs: APL0406, GIMEMA-SAL-APL0406, EUDRACT-2006-006188-22, GIMEMA-DSL-APL0406, EU-20725, NCT00482833

14.

Phase: Phase III
Type: Biomarker/Laboratory analysis, Treatment
Status: Closed
Age: 18 and over
Sponsor: NCI, Other
Protocol IDs: CDR0000553210, S0521, U10CA032102, SWOG-S0521, NCT00492856

15.

Phase: Phase III
Type: Treatment
Status: Completed
Age: 61 and over
Sponsor: Other
Protocol IDs: AMLSG06-04, NCT00151255

16.

Phase: Phase III
Type: Biomarker/Laboratory analysis, Treatment
Status: Temporarily closed
Age: 2 to 21
Sponsor: NCI
Protocol IDs: COG-AAML0631, COG-AAML0631, AAML0631, NCT00866918

17.

Phase: Phase II, Phase I
Type: Treatment
Status: Closed
Age: 18 to 70
Sponsor:
Protocol IDs: EORTC-06941

18.

Phase: Phase II, Phase I
Type: Treatment
Status: Closed
Age: 18 and over
Sponsor: Other
Protocol IDs: REK-Vestnr21503, NCT00175812

19.

Phase: Phase II, Phase I
Type: Biomarker/Laboratory analysis, Treatment
Status: Closed
Age: 18 and over
Sponsor: NCI, Other
Protocol IDs: 06-054, MSKCC-06054, NCT00382200

20.

Phase: Phase II
Type: Treatment
Status: Completed
Age: 15 and over
Sponsor: NCI
Protocol IDs: UPCC-3493, NCI-T93-0061D, T93-0061

21.

Phase: Phase II
Type: Prevention
Status: Completed
Age: Under 18
Sponsor: NCI
Protocol IDs: NCI-95-C-0144C, NCI-T95-0013N, T95-0013

22.

Phase: Phase II
Type: Treatment
Status: Closed
Age: no age specified
Sponsor: NCI
Protocol IDs: PCI-9437, NCI-T94-0173D, T94-0173

23.

Phase: Phase II
Type: Treatment
Status: Closed
Age: 18 and over
Sponsor: Pharmaceutical / Industry
Protocol IDs: YALE-HIC-8592, NCI-V96-0889

24.

Phase: Phase II
Type: Treatment
Status: Completed
Age: 21 and under
Sponsor: NCI
Protocol IDs: NCI-96-C-0117F, NCI-T96-0035N, T96-0035

25.

Phase: Phase II
Type: Treatment
Status: Completed
Age: 18 and over
Sponsor: NCI
Protocol IDs: DFCI-96278, NCI-T96-0112, T96-0112
1     
New Search